Helping organizations engage people and uncover insight from data to shape the products, services and experiences they offer
Learn MoreHelping organizations engage people and uncover insight from data to shape the products, services and experiences they offer
Learn MorePlease visit the COVID-19 response page for resources and advice on managing through the crisis today and beyond.
Helping organizations engage people and uncover insight from data to shape the products, services and experiences they offer
Learn MoreHelping organizations engage people and uncover insight from data to shape the products, services and experiences they offer
Learn MoreA major orthopedic medical device manufacturer faced slowing revenue collections from healthcare payers. A lack of systems and process integration also made it difficult to identify or address root causes for the rising percentage of pended claims. Adding to its costs and collections woes, the manufacturer’s field sales representatives were not gathering insurance eligibility information before distributing products. The company needed to improve collections while reducing costs. It collaborated with Cognizant's life sciences technology experts for our front-to-back office expertise and our experience in medical device revenue cycle management.
In the back office, we redesigned the client’s billing and collection processes for faster and higher revenue realization. This included taking over insurance preauthorization verification and implementing proactive appeals. In the front office, Cognizant helped field sales representatives to confirm patient benefits eligibility before they release product, which improved collection rates.
We also developed a descriptive analytics dashboard to improve payer management, using historical data to score payers based on risk of denial or underpayment. Collaborating with the client, we integrated explanation of benefits data from payer websites for quick resolution of unapplied cash.
The reengineered solution has helped the manufacturer save $1.18 million in operating costs, while increasing net revenue by $8.82 million. Days sales outstanding (DSO) decreased by half, from 72 days to 36 days. Results also included a reimbursement rate increase from 82% to 91% and a 12% increase in productivity.
saved in operating costs
increase in net revenue
decrease in DSO, from 72 days to 36 days
increase in productivity
VIEW
Life SciencesOur Media & Publications